Treatment for Dyspepsia
For adults without alarm features, start with non-invasive H. pylori testing ("test and treat") and eradicate if positive; if negative or symptoms persist after eradication, initiate empirical acid suppression with a proton pump inhibitor (PPI) at the lowest effective dose. 1
Initial Assessment and Risk Stratification
The management pathway depends critically on age and presence of alarm features:
When to Proceed Directly to Endoscopy
- Age ≥55 years with weight loss → urgent endoscopy 1
- Age >40 years from high gastric cancer risk areas OR family history of gastro-esophageal cancer → urgent endoscopy 1
- Age ≥60 years with abdominal pain AND weight loss → urgent CT scan to exclude pancreatic cancer 1
- Age ≥55 years with treatment-resistant dyspepsia OR raised platelet count OR nausea/vomiting → non-urgent endoscopy 1
Important caveat: The older 2005 AGA guideline used age >55 as the cutoff 2, but the more recent 2022 British Society of Gastroenterology guideline uses ≥55 years 1. The 2017 ACG/CAG guideline suggests ≥60 years but notes that higher-risk patients (childhood in high gastric cancer country, positive family history) could be offered endoscopy at younger ages 3.
For Patients Without Alarm Features (Age <55 years)
The "test and treat" strategy is the cornerstone of initial management 1:
Perform non-invasive H. pylori testing using either:
- Carbon-13 urea breath test (preferred)
- Stool antigen test
If H. pylori positive: Provide eradication therapy (strong recommendation, high-quality evidence) 1
If H. pylori negative OR symptoms persist after successful eradication: Initiate empirical acid suppression therapy
First-Line Pharmacologic Treatment
H. pylori Eradication (When Positive)
Eradication therapy is highly efficacious for H. pylori-positive functional dyspepsia (strong recommendation, high-quality evidence) 1. The 2024 ACG guideline on H. pylori treatment recommends:
- Bismuth quadruple therapy for 14 days as the preferred empiric regimen when antibiotic susceptibility is unknown 4
- Alternative: Rifabutin triple therapy or potassium-competitive acid blocker dual therapy for 14 days (in patients without penicillin allergy) 4
Key point: Confirm eradication only in patients at increased risk of gastric cancer (strong recommendation, low-quality evidence) 1
Acid Suppression for H. pylori-Negative Patients
PPIs are the first-line pharmacologic treatment for functional dyspepsia (strong recommendation, high-quality evidence) 1:
- Use the lowest dose that controls symptoms (no dose-response relationship demonstrated) 1
- Trial for 4-8 weeks 2, 3
- Well tolerated with minimal adverse effects 1
Alternative: H2-receptor antagonists may be efficacious but represent a weaker recommendation (weak recommendation, low-quality evidence) 1
Prokinetic Agents
Some prokinetics may be efficacious, but:
- Efficacy varies by drug class 1
- Many unavailable outside Asia and USA 1
- Weak recommendation for acotiamide, itopride, mosapride (low-quality evidence) 1
- Stronger recommendation for tegaserod (moderate-quality evidence) 1
Lifestyle Modifications
All patients should be advised to take regular aerobic exercise (strong recommendation, very low-quality evidence) 1
Important limitation: There is insufficient evidence to recommend specific dietary therapies, including low-FODMAP diets (weak recommendation, very low-quality evidence) 1
Second-Line Treatment (For Refractory Symptoms)
Tricyclic Antidepressants (TCAs)
TCAs are the evidence-based second-line treatment for functional dyspepsia (strong recommendation, moderate-quality evidence) 1:
- Start with amitriptyline 10 mg once daily
- Titrate slowly to maximum 30-50 mg once daily
- Can be initiated in primary or secondary care
- Critical counseling point: Explain these are used as "gut-brain neuromodulators," NOT for depression, to improve adherence
- Discuss side effect profile upfront (anticholinergic effects, sedation)
Alternative Second-Line Options
- Antipsychotics (sulpiride 100 mg four times daily or levosulpiride 25 mg three times daily) may be efficacious but require careful explanation and counseling about side effects 1
Management Algorithm Summary
- Age ≥55 with alarm features → Endoscopy
- Age <55 without alarm features → Non-invasive H. pylori test
- If positive → Eradicate
- If negative → PPI trial (4-8 weeks)
- If PPI fails → Consider TCA (amitriptyline 10-50 mg daily)
- If still refractory → Consider prokinetics or antipsychotics
- Severe/refractory cases → Multidisciplinary team, avoid opioids and surgery 1
Common Pitfalls to Avoid
- Don't routinely perform gastric emptying testing or 24-hour pH monitoring in typical functional dyspepsia (strong recommendation, very low-quality evidence) 1
- Don't use endoscopy in young patients (<55) without alarm features as initial investigation—this is not cost-effective 2
- Don't repeat clarithromycin in second-line H. pylori eradication if used in first-line 5
- Don't use levofloxacin-containing regimens as first-line in non-penicillin-allergic patients 5
- Avoid opioids and surgery in severe/refractory functional dyspepsia to minimize iatrogenic harm (strong recommendation, very low-quality evidence) 1
When to Refer to Gastroenterology
Referral is appropriate when:
- Diagnostic doubt exists
- Symptoms are severe or refractory to first-line treatments
- Patient requests specialist opinion (weak recommendation, low-quality evidence) 1